Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE SCIENCES vs WYETH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE SCIENCES WYETH SUVEN LIFE SCIENCES/
WYETH
 
P/E (TTM) x -20.5 27.7 - View Chart
P/BV x 5.8 11.3 51.4% View Chart
Dividend Yield % 0.0 10.9 -  

Financials

 SUVEN LIFE SCIENCES   WYETH
EQUITY SHARE DATA
    SUVEN LIFE SCIENCES
Mar-23
WYETH
Mar-14
SUVEN LIFE SCIENCES/
WYETH
5-Yr Chart
Click to enlarge
High Rs941,065 8.8%   
Low Rs45553 8.1%   
Sales per share (Unadj.) Rs0.6289.5 0.2%  
Earnings per share (Unadj.) Rs-5.438.7 -14.0%  
Cash flow per share (Unadj.) Rs-5.139.9 -12.8%  
Dividends per share (Unadj.) Rs0145.00 0.0%  
Avg Dividend yield %017.9 0.0%  
Book value per share (Unadj.) Rs17.2118.5 14.5%  
Shares outstanding (eoy) m218.0722.72 959.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x111.82.8 3,998.9%   
Avg P/E ratio x-12.820.9 -61.2%  
P/CF ratio (eoy) x-13.520.3 -66.8%  
Price / Book Value ratio x4.06.8 59.1%  
Dividend payout %0374.7 -0.0%   
Avg Mkt Cap Rs m15,13118,381 82.3%   
No. of employees `000NANA-   
Total wages/salary Rs m186359 51.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m1356,577 2.1%  
Other income Rs m84347 24.3%   
Total revenues Rs m2206,925 3.2%   
Gross profit Rs m-1,1961,023 -116.9%  
Depreciation Rs m6527 239.0%   
Interest Rs m54 122.6%   
Profit before tax Rs m-1,1831,339 -88.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m0460 0.0%   
Profit after tax Rs m-1,183879 -134.5%  
Gross profit margin %-883.615.6 -5,680.1%  
Effective tax rate %034.3 -0.0%   
Net profit margin %-873.513.4 -6,534.8%  
BALANCE SHEET DATA
Current assets Rs m3,4553,964 87.2%   
Current liabilities Rs m1,0502,081 50.5%   
Net working cap to sales %1,776.028.6 6,204.1%  
Current ratio x3.31.9 172.7%  
Inventory Days Days3,94835 11,250.5%  
Debtors Days Days218278 78.4%  
Net fixed assets Rs m1,373878 156.4%   
Share capital Rs m218227 96.0%   
"Free" reserves Rs m3,5352,466 143.4%   
Net worth Rs m3,7532,693 139.4%   
Long term debt Rs m025 0.0%   
Total assets Rs m4,8284,842 99.7%  
Interest coverage x-218.8306.0 -71.5%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x01.4 2.1%   
Return on assets %-24.418.2 -133.6%  
Return on equity %-31.532.6 -96.5%  
Return on capital %-31.449.4 -63.5%  
Exports to sales %40.40.1 35,026.0%   
Imports to sales %839.834.7 2,421.5%   
Exports (fob) Rs m558 721.3%   
Imports (cif) Rs m1,1372,281 49.8%   
Fx inflow Rs m558 719.4%   
Fx outflow Rs m1,1372,298 49.5%   
Net fx Rs m-1,082-2,291 47.2%   
CASH FLOW
From Operations Rs m-1,0311,188 -86.8%  
From Investments Rs m-2,606287 -908.6%  
From Financial Activity Rs m3,955-4,296 -92.1%  
Net Cashflow Rs m317-2,821 -11.3%  

Share Holding

Indian Promoters % 69.6 0.0 -  
Foreign collaborators % 0.0 51.1 -  
Indian inst/Mut Fund % 0.6 18.4 3.0%  
FIIs % 0.5 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 48.9 62.3%  
Shareholders   74,003 25,706 287.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE SCIENCES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Suven Life Sciences vs WYETH

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Suven Life Sciences vs WYETH Share Price Performance

Period Suven Life Sciences WYETH S&P BSE HEALTHCARE
1-Day 0.30% -2.27% 1.18%
1-Month -2.06% 18.58% -0.75%
1-Year 114.92% 69.59% 61.82%
3-Year CAGR 14.94% 15.36% 18.16%
5-Year CAGR -16.22% 8.95% 19.79%

* Compound Annual Growth Rate

Here are more details on the Suven Life Sciences share price and the WYETH share price.

Moving on to shareholding structures...

The promoters of Suven Life Sciences hold a 69.6% stake in the company. In case of WYETH the stake stands at 51.1%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Suven Life Sciences and the shareholding pattern of WYETH.

Finally, a word on dividends...

In the most recent financial year, Suven Life Sciences paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

WYETH paid Rs 145.0, and its dividend payout ratio stood at 374.7%.

You may visit here to review the dividend history of Suven Life Sciences, and the dividend history of WYETH.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.